LATAM Cargo and Delta Cargo are joining forces to integrate their pharma networks, providing more route options between North and South America.

This partnership enhances service for customers with time-sensitive pharmaceutical shipments, offering expanded routing choices, additional capacity, and optimised transit times.

The collaboration establishes key transfer points in Atlanta (ATL), New York-JFK (JFK), and Miami (MIA), streamlining the transfer process between the two airlines. This will allow for faster, more reliable delivery of sensitive pharmaceutical products, ensuring they reach their destinations safely and efficiently across the Americas.

Delta Cargo has expanded the size of its pharma network of stations by 36.8% with the addition of new stations including Miami (MIA) and Curitiba (CWB). Meanwhile, LATAM Group increased the size of its pharma network of stations by 52.9%, by integrating Delta stations including Detroit (DTW) and Philadelphia (PHL).

Andrés Varela, commercial director for North America and Asia at LATAM Cargo Group, said: “This announcement represents a major tangible benefit of our joint venture with Delta Cargo. At LATAM Cargo Group, we are continually seeking new solutions to bring more opportunities to our clients, while always maintaining the highest standards of quality in all our services. Through this partnership, we strengthen our pharma network and provide pharmaceutical clients with greater options to diversify origins and destinations, ensuring that these critical products reach their destinations with maximum safety and efficiency.

Peter Penseel, president of Delta Cargo, said: “By expanding our joint pharmaceutical capabilities, we are not only providing more options for our customers, but also ensuring that vital medical supplies reach their destinations with the utmost reliability and speed. This milestone is a testament to our shared vision of providing superior service for our mutual customers across North and South America.”

READ MORE NEWS: Delta Cargo makes history with CEIV Pharma certification at JFK